000			01933 a2200613 4500
005			20250518020156.0
264		0	_c20200109
008			202001s 0 0 eng d
022			_a2473-9537
024	7		_a10.1182/bloodadvances.2018026401 _2doi
040			_aNLM _beng _cNLM
100	1		_aLandsburg, Daniel J
245	0	0	_aOutcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy. _h[electronic resource]
260			_bBlood advances _c01 2019
300			_a132-135 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenine _xanalogs & derivatives
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aBiomarkers, Tumor
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aFemale
650	0	4	_aGenes, bcl-2
650	0	4	_aGenes, myc
650	0	4	_aHumans
650	0	4	_aLymphoma, B-Cell _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPiperidines
650	0	4	_aPrognosis
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aPyrazoles _xadministration & dosage
650	0	4	_aPyrimidines _xadministration & dosage
650	0	4	_aRecurrence
650	0	4	_aRetreatment
650	0	4	_aTreatment Outcome
700	1		_aHughes, Mitchell E
700	1		_aKoike, Alexa
700	1		_aBond, David
700	1		_aMaddocks, Kami J
700	1		_aGuo, Ling
700	1		_aWinter, Allison M
700	1		_aHill, Brian T
700	1		_aOndrejka, Sarah L
700	1		_aHsi, Eric D
700	1		_aNasta, Sunita D
700	1		_aSvoboda, Jakub
700	1		_aSchuster, Stephen J
700	1		_aBogusz, Agata M
773	0		_tBlood advances _gvol. 3 _gno. 2 _gp. 132-135
856	4	0	_uhttps://doi.org/10.1182/bloodadvances.2018026401 _zAvailable from publisher's website
999			_c29262149 _d29262149